GURUFOCUS.COM » STOCK LIST » Financial Services » Diversified Financial Services » BioPlus Acquisition Corp (NAS:BIOS) » Definitions » Price-to-Tangible-Book
中文

BioPlus Acquisition (BioPlus Acquisition) Price-to-Tangible-Book : 1.72 (As of Apr. 24, 2024)


View and export this data going back to 2022. Start your Free Trial

What is BioPlus Acquisition Price-to-Tangible-Book?

As of today (2024-04-24), BioPlus Acquisition's share price is $10.795. BioPlus Acquisition's Tangible Book per Share of Jun. 2023 for the quarter that ended in Jun. 2023 was $6.29. Hence, BioPlus Acquisition's Price to Tangible Book Ratio of today is 1.72.

The historical rank and industry rank for BioPlus Acquisition's Price-to-Tangible-Book or its related term are showing as below:

BIOS' s Price-to-Tangible-Book Range Over the Past 10 Years
Min: 1.31   Med: 1.34   Max: 1.72
Current: 1.72

During the past 2 years, BioPlus Acquisition's highest Price to Tangible Book Ratio was 1.72. The lowest was 1.31. And the median was 1.34.

BIOS's Price-to-Tangible-Book is not ranked
in the Diversified Financial Services industry.
Industry Median: 1.82 vs BIOS: 1.72

A closely related ratio is called PB Ratio. As of today, BioPlus Acquisition's share price is $10.795. BioPlus Acquisition's Book Value per Sharefor the quarter that ended in Jun. 2023 was $6.29. Hence, BioPlus Acquisition's P/B Ratio of today is 1.72.


BioPlus Acquisition Price-to-Tangible-Book Historical Data

The historical data trend for BioPlus Acquisition's Price-to-Tangible-Book can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BioPlus Acquisition Price-to-Tangible-Book Chart

BioPlus Acquisition Annual Data
Trend Dec21 Dec22
Price-to-Tangible-Book
- 1.34

BioPlus Acquisition Quarterly Data
Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23
Price-to-Tangible-Book Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.32 1.33 1.34 1.36 1.69

Competitive Comparison of BioPlus Acquisition's Price-to-Tangible-Book

For the Shell Companies subindustry, BioPlus Acquisition's Price-to-Tangible-Book, along with its competitors' market caps and Price-to-Tangible-Book data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


BioPlus Acquisition's Price-to-Tangible-Book Distribution in the Diversified Financial Services Industry

For the Diversified Financial Services industry and Financial Services sector, BioPlus Acquisition's Price-to-Tangible-Book distribution charts can be found below:

* The bar in red indicates where BioPlus Acquisition's Price-to-Tangible-Book falls into.



BioPlus Acquisition Price-to-Tangible-Book Calculation

BioPlus Acquisition's price-to-tangible-book ratio for today is calculated as:

Price to Tangible Book=Share Price/Tangible Book per Share (Q: Jun. 2023 )
=10.795/6.292
=1.72

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

A closely related ratio is called PB Ratio. The difference between Price-to-Tangible-Book Ratio and PB Ratio is that book value other than intangibles are used in the calculation.


Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The Price-to-Book Ratio does not work well for these companies. Some companies even have negative equity, so the Price-to-Book Ratio cannot be applied to them.


BioPlus Acquisition Price-to-Tangible-Book Related Terms

Thank you for viewing the detailed overview of BioPlus Acquisition's Price-to-Tangible-Book provided by GuruFocus.com. Please click on the following links to see related term pages.


BioPlus Acquisition (BioPlus Acquisition) Business Description

Traded in Other Exchanges
N/A
Address
260 Madison Avenue, Suite 800, New York, NY, USA, 10026
Website
BioPlus Acquisition Corp is a blank check company.
Executives
Steven C. Fletcher 10 percent owner C/O LEE ENTERPRISES, INCORPORATED, 4600 EAST 53RD STREET, DAVENPORT IA 52807
Explorer Parent Llc 10 percent owner 533 AIRPORT BOULEVARD, SUITE 400, BURLINGAME CA 94012
Founder Holdings Llc 10 percent owner 533 AIRPORT BOULEVARD, SUITE 400, BURLINGAME CA 94012
Alex Serge Vieux 10 percent owner C/O COMPUTER ASSOCIATES INTER INC, ONE COMPUTER ASSOC PLAZA, ISLANDIA NY 11749
Bioplus Sponsor Llc 10 percent owner 544 AIRPORT BOULEVARD, SUITE 400, BURLINGAME CA 94010
Stephen A Sherwin director C/O CELL GENESYS, INC., 500 FORBES BLVD., SOUTH SAN FRANCISCO CA 94080
Louis G Lange director 3172 PORTER DRIVE, PALO ALTO CA 94034
Ross Haghighat director, officer: CEO and CFO C/O ADURO BIOTECH, INC., 626 BANCROFT WAY, 3C, BERKELEY CA 94710
Ronald W Eastman director 335 BRYANT STREET, THIRD FLOOR, PALO ALTO CA 94301
Shawn Cross director 1825 K STREET SUITE 510, WASHINGTON DC 20006
Jonathan Rigby director, officer: Chief Business Officer ARADIGM CORPORATION, 3929 POINT EDEN WAY, HAYWARD CA 94545
Glen Giovannetti director UNIT 6706, THE CENTER, 99 QUEEN'S ROAD CENTRAL, HONG KONG K3 00000